1Yam JL, et al. BMJ Case Rep 2018. doi:10.1136/bcr-2017-223991

Sarcomatoid carcinoma of the duodenumJulie L Yam,1 Manoj P Rai,2 Divyesh Reddy Nemakayala,2 Varunsiri Atti2

Images in…

To cite: Yam JL, Rai MP, Nemakayala DR, et al. BMJ Case Rep Published Online First: [please include Day Month Year]. doi:10.1136/bcr-2017-223991

1Gastroenterology, McLaren of Greater Lansing, Lansing, Michigan2Internal Medicine, Michigan State University / Sparrow Hospital, Lansing, Michigan, United States of America

Correspondence toDr Manoj P Rai, manojrai029@ gmail. com

VA contributed equally.

Accepted 27 December 2017

DesCripTionA 69-year-old Caucasian man presented to the gastroenterology clinic with complaints of nausea, abdominal pain and more than 100-pound uninten-tional weight loss over the past 1 year. He had a

history of colon polyps and was overdue for surveil-lance colonoscopy. He was subsequently scheduled for an outpatient oesophagogastroduodenoscopy (EGD) and colonoscopy as initial work-up for his symptoms. One week later, the patient underwent

Figure 1 Oesophagogastroduodenoscopy showing ulcerated mass in the second portion of the duodenum.

Figure 2 H&E stain showing features of pleomorphic cells without glandular differentiation.

Figure 3 H&E stain showing features of pleomorphic cells without glandular differentiation.

Figure 4 Immunohistochemistry positive for cytokeratin AE1/AE3.

Figure 5 Immunohistochemistry positive for vimentin.

Figure 6 Immunohistochemistry focally positive for CK7.

on 14 February 2020 by guest. P

rotected by copyright.http://casereports.bm

j.com/

BM

J Case R

eports: first published as 10.1136/bcr-2017-223991 on 17 January 2018. Dow

nloaded from

2 Yam JL, et al. BMJ Case Rep 2018. doi:10.1136/bcr-2017-223991

images in…

endoscopy. EGD showed an ulcerated mass in the second portion of the duodenum (figure 1). Biopsy of the lesion showed features of pleomorphic cells without glandular differentiation (figures 2 and 3). Immunohistochemical studies revealed pleo-morphic cells positive for cytokeratin AE1/AE3 (figure 4), CAM 5.2 and vimentin (figure 5), focally positive for CK7 (figure 6), and weakly for CK20. They were negative for neuroendocrine markers chromogranin, synaptophysin, and CD45 which is a lymphoid marker. Additional stains such as discovered on GIST - 1 (DOG-1), C-kit, mouse double minute 2 homolog (MDM2), S-100 and ERG were performed, which were negative. The morphological features and the immunohistochemistry findings were consistent with sarcomatoid carcinoma. A second opinion was sought at a nearby tertiary care centre, and the diagnosis was

confirmed. Colonoscopy was negative except for mild divertic-ulosis in the sigmoid colon. Positron emission tomography-CT demonstrated heterogeneous fluorodeoxyglucose (FDG) active mass in the left upper to a midabdominal area, FDG active mass in the distal pancreatic body, multiple FDG active liver metas-tasis and mildly FDG active sclerotic focus in the T11 vertebral body (figure 7). The patient was offered palliative radiation, but he was unable to start treatment due to fatigue and poor performance status. He eventually opted for home hospice. Sarcomatoid carcinoma displays properties of both epithelial and mesenchymal carcinomas. It is a rare neoplasm of the small intestine with approximately 30 cases reported to date.1 2 Immu-nohistochemical analysis is necessary to establish a diagnosis since H&E stain exam is not conclusive. Vimentin is positive in approximately 90% of intestinal sarcomatoid carcinomas.1 Neuroendocrine and neuron-specific markers may be positive in some cases; however, in our case, it was negative.1 Surgical resec-tion is the first choice of therapy for sarcomatoid carcinoma of the small intestine.2 3 Neither radiotherapy nor chemotherapy is known to enhance survival.2 Sarcomatoid carcinoma is a highly malignant tumour with high mortality,2 with only a few months of survival duration.2 3 In our case the patient survived for 2 months since the date of diagnosis.

Contributors JY performed the EGD and wrote the case description. MPR wrote the description, learning points and edited the draft. MR edited the draft. VA edited the draft.

Competing interests None declared.

patient consent Obtained.

provenance and peer review Not commissioned; externally peer reviewed.

© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

RefeRences 1 Han N, Han QH, Liu YZ, et al. Perforated sarcomatoid carcinoma of the jejunum: case

report. Oncol Lett 2013;6:562–4. 2 Reid-Nicholson M, Idrees M, Perino G, et al. Sarcomatoid carcinoma of the

small intestine: a case report and review of the literature. Arch Pathol Lab Med 2004;128:918–21.

3 Moriwaki Y, Sugiyama M. Severe anemia inducing preshock caused by sarcomatoid carcinoma of the small intestine. Int Surg 2009;94:164–70.

Figure 7 Positron emission tomography-CT demonstrating fluorodeoxyglucose active liver metastasis.

Learning points

► Sarcomatoid carcinoma is a rare tumour of the duodenum. Its diagnosis is difficult with H&E staining alone, so immunohistochemistry is always necessary.

► Sarcomatoid carcinoma is a highly malignant tumour with poor prognosis.

on 14 February 2020 by guest. P

rotected by copyright.http://casereports.bm

j.com/

BM

J Case R

eports: first published as 10.1136/bcr-2017-223991 on 17 January 2018. Dow

nloaded from

3Yam JL, et al. BMJ Case Rep 2018. doi:10.1136/bcr-2017-223991

images in…

Copyright 2017 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visithttp://group.bmj.com/group/rights-licensing/permissions.BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.

Become a Fellow of BMJ Case Reports today and you can: ► Submit as many cases as you like ► Enjoy fast sympathetic peer review and rapid publication of accepted articles ► Access all the published articles ► Re-use any of the published material for personal use and teaching without further permission

For information on Institutional Fellowships contact consortiasales@bmjgroup.com

Visit casereports.bmj.com for more articles like this and to become a Fellow

on 14 February 2020 by guest. P

rotected by copyright.http://casereports.bm

j.com/

BM

J Case R

eports: first published as 10.1136/bcr-2017-223991 on 17 January 2018. Dow

nloaded from